SK
Shifali Kher
About Shifali Kher
Data last updated:
Shifali Kher is a Director at Nuberg Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Nuberg Pharmaceuticals Private Limited reported revenue of ₹3.17 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nuberg Pharmaceuticals Private Limited U51909PB2017PTC047148 | Director | 07 Nov 2017 | 2017 | ₹3.17 Cr (FY 2025) | Active |
Board colleagues of Shifali Kher
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pardeep Malhotra | 07977064 | Nuberg Pharmaceuticals Private Limited | Director |
| Sumit Kher | 07977078 | Nuberg Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shifali Kher
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shifali Kher
Shifali Kher currently holds 1 directorship: Nuberg Pharmaceuticals Private Limited (Director, since 07 Nov 2017, revenue ₹3.17 Cr (FY 2025)).
Shifali Kher was first appointed on 07 Nov 2017 as Director at Nuberg Pharmaceuticals Private Limited.
The current boards of Shifali Kher's companies include Pardeep Malhotra (Nuberg Pharmaceuticals Private Limited), Sumit Kher (Nuberg Pharmaceuticals Private Limited).